Ticker: NTLA

Company: Intellia Therapeutics, Inc.

Person: Dulac Edward J III, officer

Transaction date: Jan. 5, 2026

Reporting date: Jan. 7, 2026

Average share price: 9.21

Sold 6379.0 shares for 58750.59